CJC-1295 No DAC & Ipamorelin – Dual-Mechanism Growth Hormone Research

This peptide blend combines CJC-1295 without DAC, a Growth Hormone-Releasing Hormone (GHRH) analog, with Ipamorelin, a selective Growth Hormone-Releasing Peptide. Together, they stimulate two complementary signaling pathways in research models to promote growth hormone release.

Each vial contains 2mg of CJC-1295 (No DAC) and 2mg of Ipamorelin, formulated for synergistic GH pathway exploration.

Why Combine These Peptides?

CJC-1295 (No DAC) acts on the GHRH receptor, promoting natural GH pulse patterns, while Ipamorelin binds to the ghrelin receptor with high selectivity, avoiding many of the side effects associated with older GHRPs. This combination is frequently studied for its potential to enhance GH release without excessive cortisol or prolactin elevation.

Research Applications

• Growth hormone release studies
• GHRH + GHRP synergistic pathway analysis
• Endocrine and pituitary function models
• Metabolic and recovery research
• Regeneration and tissue repair studies

Scientific Background

CJC-1295 without DAC provides shorter, more natural GH release pulses in contrast to its DAC version, making it suitable for certain experimental designs. Ipamorelin is known for its clean receptor profile, stimulating GH release through the ghrelin pathway with minimal impact on appetite or other hormonal systems, making it a favored choice in research where targeted GH stimulation is desired.

Chemical Profile

Type: Synthetic peptide blend
Contents: 2mg CJC-1295 No DAC + 2mg Ipamorelin
Appearance: Lyophilized powder
Purity: ≥98% (HPLC)

Manufactured under strict quality guidelines for research purposes only.

Storage & Handling

Store at −20°C, protected from light and moisture. After reconstitution, refrigerate at 2–8°C and use within the recommended timeframe. Avoid multiple freeze–thaw cycles.

For Research Use Only

This peptide blend is intended for in vitro laboratory research only and is not for human or veterinary use.

• GHRH – Wikipedia
• GHRP – Wikipedia
• Ipamorelin – Wikipedia